US 12325705
Small molecules for the treatment of primary cancer and cancer metastasis
granted A61KA61K31/522A61P
Quick answer
US patent 12325705 (Small molecules for the treatment of primary cancer and cancer metastasis) held by The Board of Regents of the University of Texas System expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/522, A61P, A61P35/00